ELAN Elanco Animal Health
- 13.530
- +0.060+0.45%
- 13.730
- +0.200+1.48%
Elanco Animal Health News
Express News | NYSE Order Imbalance 419856.0 Shares on Sell Side
Express News | NYSE Order Imbalance 237216.0 Shares on Buy Side
Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com
By Josh Nathan-Kazis Zoetis reported financial results for the first quarter that were slightly better than Wall Street expected as worries about its new pain medicines for dogs and cats continue to
Express News | NYSE Order Imbalance 73554.0 Shares on Sell Side
Express News | NYSE Order Imbalance 213913.0 Shares on Buy Side
Express News | NYSE Order Imbalance 210292.0 Shares on Buy Side
The Spread of Avian Flu to Cattle Could Have Implications for Some Stocks
Express News | NYSE Order Imbalance 168202.0 Shares on Buy Side
Express News | NYSE Order Imbalance 818652.0 Shares on Buy Side
Express News | NYSE Order Imbalance 72994.0 Shares on Buy Side
Express News | NYSE Order Imbalance 263927.0 Shares on Buy Side
Express News | NYSE Order Imbalance 165981.0 Shares on Buy Side 165981.0 Shares on Buy Side
Express News | NYSE Order Imbalance 128261.0 Shares on Buy Side
Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
United States Pet Medication Market Insights Report 2024-2029 Featuring Prominent Vendors - Boehringer Ingelheim, Ceva, Elanco Animal Health, Merck, Zoetis, Bayer AG, and Novartis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "U.S. Pet Medication Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. Pet Medication Market was valued at USD 13.21
Unusual Options Activity: WBD, ULTA and Others Attract Market Bets, WBD V/OI Ratio Reaches 2181.8
EST Apr 16th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend
Express News | NYSE Order Imbalance 52032.0 Shares on Buy Side
Investors Aren't Buying Elanco Animal Health Incorporated's (NYSE:ELAN) Revenues
You may think that with a price-to-sales (or "P/S") ratio of 1.7x Elanco Animal Health Incorporated (NYSE:ELAN) is a stock worth checking out, seeing as almost half of all the Pharmaceuticals companie
Express News | FDA Approved Pradalex (Pradofloxacin Injection) Solution For Certain Respiratory Diseases In Cattle And Swine; Approves New Antimicrobial Drug For Cattle And Swine; Pradalex Is Sponsored By Elanco U.S
S&P 500 Futures Flat In Premarket Trading; MicroStrategy, Marathon Digital Lead
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, MicroStrategy Inc. (MSTR) was up 11.5% in pre-marke
Analysis
Price Target
No Data
